Health · 1 sources covering this

STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its obesity and diabetes drugs appear more effective.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·5h ago
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its obesity and diabetes drugs appear more effective.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/34e182efcbccc526ba0b4039eddfa8d6506f9a6f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’"></iframe>

STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

How 1 sources are covering this

STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

More from Health

Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth

STAT+: Advocates say federal funding is being cut from groups fighting HIV

Is there an exodus underway at Epic?

STAT+: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases

Reader

Trust & legal

Across the network